Home
 Content
 Lead article
 EBI
 Bio-eye
 Events
BioInformer Logo -- click for homepage

A publication of EMBL - Outstation Hinxton, The European Bioinformatics Institute

EBI logo -- click for homepage
biobrddwn

The Industry Programme of the European Bioinformatics Institute

In 1996, the European Bioinformatics Institute launched a programme of support for industry in the field of bioinformatics. The aim of this programme is to help the pharmaceutical and biotech industries to benefit from the latest innovations in the fast-growing field of bioinformatics by providing training, plus pre-competitive research and development. To remain current, the project content is developed jointly by the EBI and its industry partners during quarterly meetings held at the EBI.

The seventeen current members of the EBI Industry Programme are:

Akzo Nobel

Novartis Pharma

AstraZeneca

Novo Nordisk

Aventis

Pfizer

Boehringer-Ingelheim

Pharmacia and Upjohn

British Biotechnology

Schering

Glaxo Wellcome

SmithKline Beecham

Hoffmann-La Roche

Synthelabo

Janssen

Unilever

Merck KGaA

 

There are five main activities in the Industry Programme:

  1. Training and education - Members have access to the training and education courses run by the Industry Programme. These courses are available to members only. Since 1996, over 40 workshops and conferences have been organised.
  2. Research - Within the group, pre-competitive research and evaluation in bioinformatics is done, e.g. data mining, visualisation, CORBA, XML, DNA microarrays and gene prediction. Members have influence over the direction of research and access to preliminary results.
  3. Development - In collaboration with other groups at the EBI, we strive to improve EBI resources as requested by our members, e.g. access to public EST data.
  4. Standards - Of interest to our members is the development of standards that will prevent them becoming locked into proprietary solutions. As a neutral organisation, the EBI has been involved with the promotion of standards for biomolecular sequence analysis, genomic maps and DNA microarray data.
  5. Industry programme meetings - Each quarter we organise a 1½ day for our members. This is not only for discussion of project progress and development, but provides an opportunity for scientists and managers in the pharmaceutical and biotech industry to discuss issues informally and network on a neutral territory.

Should you wish to learn more about the Industry Programme of the EBI, please visit the web site at http://industry.ebi.ac.uk/.

Article by: Alan Robinson


Resources and further information

External sites are not endorsed by EMBL-EBI

 

biobrddwn

Direct questions or comments to Bioinformer Editor. This page last modified Monday, 07 August, 2000.
ISSN 1462-1363.
More information about the BioInformer.

© 1997-2000 EMBL-EBI. All Rights Reserved.